Intravenous Immune Globulin (IVIG) Demonstration: Payment Update for 2022
The purpose of this Change Request (CR) is to specify the payment rate for 2022, for the Intravenous Immune Globulin (IVIG) Demonstration.
Issued by: Centers for Medicare & Medicaid Services (CMS)
Issue Date: December 02, 2021
DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.